The Future of Diabetes Therapy
Author:
McMahon Graham T.
Reference104 articles.
1. Green A, Christian Hirsch N, Pramming SK. The changing world demography of type 2 diabetes. Diabetes Metab Res Rev. Jan–Feb 2003;19(1):3–7.
2. Clarke P, Gray A, Legood R, Briggs A, Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med. Jun 2003;20(6):442–450.
3. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. Feb 7 2008;358(6):580–591.
4. Rizza RA, Vigersky RA, Rodbard HW, et al. A model to determine workforce needs for endocrinologists in the United States until 2020. Endocr Pract. May–Jun 2003;9(3):210–219.
5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. Feb 7 2002;346(6):393–403.